The new German evidence-based guideline on diffuse large B-cell lymphoma —key aspects for radiation oncologists

ConclusionRT remains an integral part of the treatment repertoire of DLBCL. With the use of PET-guided treatment, RT is indicated for patients with metabolically active tumors. In the context of the ongoing development of targeted therapies, new RT indications may evolve.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research